Ewan Livesey

Ewan Livesey is the Chief Corporate Development Officer at Rosemont Pharmaceuticals and a Co-Founder of Nucleo. He also serves as a Member of the Advisory Board at SYNAP IoT. Additionally, he is the Founder and Managing Director of Birnam Oak, a consultancy providing services in business and corporate development to the Life Science and Financial Services Sectors. Ewan has held various roles in business development and corporate development at companies such as Flynn Pharma, Norgine, Zentiva, Apotex Inc., Lupin Atlantis Holdings SA, and Glenmark Pharmaceuticals Europe. Ewan holds a Dip EU Law from King's College London, Law Society Finals from the College of Law, Lancaster Gate, London, and an LLB (Hons) in Laws from Queen Mary University of London.